» Articles » PMID: 24123475

Functional Connectivity Changes Differ in Early and Late-onset Alzheimer's Disease

Overview
Journal Hum Brain Mapp
Publisher Wiley
Specialty Neurology
Date 2013 Oct 15
PMID 24123475
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

At a similar stage, patients with early onset Alzheimer's disease (EOAD) have greater neocortical but less medial temporal lobe dysfunction and atrophy than the late-onset form of the disease (LOAD). Whether the organization of neural networks also differs has never been investigated. This study aims at characterizing basal functional connectivity (FC) patterns of EOAD and LOAD in two groups of 14 patients matched for disease duration and severity, relative to age-matched controls. All subjects underwent an extensive neuropsychological assessment. Magnetic resonance imaging was used to quantify atrophy and resting-state FC focusing on : the default mode network (DMN), found impaired in earlier studies on AD, and the anterior temporal network (ATN) and dorso-lateral prefrontal network (DLPFN), respectively involved in declarative memory and executive functions. Patterns of atrophy and cognitive impairment in EOAD and LOAD were in accordance with previous reports. FC within the DMN was similarly decreased in both EOAD and LOAD relative to controls. However, a double-dissociated pattern of FC changes in ATN and DLPFN was found. EOAD exhibited decreased FC in the DLPFN and increased FC in the ATN relative to controls, while the reverse pattern was found in LOAD. In addition, ATN and DLPFN connectivity correlated respectively with memory and executive performances, suggesting that increased FC is here likely to reflect compensatory mechanisms. Thus, large-scale neural network changes in EOAD and LOAD endorse both common features and differences, probably related to a distinct distribution of pathological changes.

Citing Articles

Functional and effective EEG connectivity patterns in Alzheimer's disease and mild cognitive impairment: a systematic review.

Paitel E, Otteman C, Polking M, Licht H, Nielson K Front Aging Neurosci. 2025; 17:1496235.

PMID: 40013094 PMC: 11861106. DOI: 10.3389/fnagi.2025.1496235.


Hyperconnectivity and Connectome Gradient Dysfunction of Cerebello-Thalamo-Cortical Circuitry in Alzheimer's Disease Spectrum Disorders.

Yao C, Shan Y, Cui B, Chen Z, Bi S, Wang T Cerebellum. 2025; 24(2):43.

PMID: 39913059 DOI: 10.1007/s12311-025-01792-4.


Compensation versus deterioration across functional networks in amnestic mild cognitive impairment subtypes.

Varela-Lopez B, Zurron M, Lindin M, Diaz F, Galdo-Alvarez S Geroscience. 2024; .

PMID: 39367933 DOI: 10.1007/s11357-024-01369-9.


Diverging Relationships among Amyloid, Tau, and Brain Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.

Na H, Shin J, Kim S, Seo S, Kim W, Kang J Yonsei Med J. 2024; 65(8):434-447.

PMID: 39048319 PMC: 11284308. DOI: 10.3349/ymj.2023.0308.


SuperAging functional connectomics from resting-state functional MRI.

Diamond B, Sridhar J, Maier J, Martersteck A, Rogalski E Brain Commun. 2024; 6(4):fcae205.

PMID: 38978723 PMC: 11228547. DOI: 10.1093/braincomms/fcae205.


References
1.
Kim E, Cho S, Jeong Y, Park K, Kang S, Kang E . Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain. 2005; 128(Pt 8):1790-801. DOI: 10.1093/brain/awh539. View

2.
SELTZER B, SHERWIN I . A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two?. Arch Neurol. 1983; 40(3):143-6. DOI: 10.1001/archneur.1983.04050030037006. View

3.
Das S, Pluta J, Mancuso L, Kliot D, Orozco S, Dickerson B . Increased functional connectivity within medial temporal lobe in mild cognitive impairment. Hippocampus. 2012; 23(1):1-6. PMC: 3642853. DOI: 10.1002/hipo.22051. View

4.
Hedden T, Van Dijk K, Becker J, Mehta A, Sperling R, Johnson K . Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci. 2009; 29(40):12686-94. PMC: 2808119. DOI: 10.1523/JNEUROSCI.3189-09.2009. View

5.
Vanderstichele H, De Vreese K, Blennow K, Andreasen N, Sindic C, Ivanoiu A . Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. Clin Chem Lab Med. 2006; 44(12):1472-80. DOI: 10.1515/CCLM.2006.258. View